Cargando…
Benefits from Treatment and Control of Patients with Resistant Hypertension
Resistant hypertension is commonly found in everyday clinical practice. However, the risks of resistant hypertension, as well as the benefits of treatment and control of blood pressure in patients with resistant hypertension remain vaguely clarified. Data from small clinical studies and observationa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014695/ https://www.ncbi.nlm.nih.gov/pubmed/21234402 http://dx.doi.org/10.4061/2011/318549 |
_version_ | 1782195372694700032 |
---|---|
author | Doumas, Michael Papademetriou, Vasilios Douma, Stella Faselis, Charles Tsioufis, Konstantinos Gkaliagkousi, Eugene Petidis, Konstantinos Zamboulis, Chrysanthos |
author_facet | Doumas, Michael Papademetriou, Vasilios Douma, Stella Faselis, Charles Tsioufis, Konstantinos Gkaliagkousi, Eugene Petidis, Konstantinos Zamboulis, Chrysanthos |
author_sort | Doumas, Michael |
collection | PubMed |
description | Resistant hypertension is commonly found in everyday clinical practice. However, the risks of resistant hypertension, as well as the benefits of treatment and control of blood pressure in patients with resistant hypertension remain vaguely clarified. Data from small clinical studies and observational cohorts suggest that patients with resistant hypertension are at increased cardiovascular risk, while control of blood pressure offers substantial benefits. It has to be noted however that data from appropriate large randomized studies are missing, and resistant hypertension remains remarkably understudied. Resistant hypertension has attracted significant scientific interest lately, as new therapeutic modalities become available. The interventional management of resistant hypertension either by carotid baroreceptor stimulation or renal sympathetic denervation is currently under investigation with promising preliminary results. This review presents available evidence regarding the benefits of treatment and control of blood pressure in patients with resistant hypertension and offers a critical evaluation of existing data in this field. |
format | Text |
id | pubmed-3014695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-30146952011-01-13 Benefits from Treatment and Control of Patients with Resistant Hypertension Doumas, Michael Papademetriou, Vasilios Douma, Stella Faselis, Charles Tsioufis, Konstantinos Gkaliagkousi, Eugene Petidis, Konstantinos Zamboulis, Chrysanthos Int J Hypertens Review Article Resistant hypertension is commonly found in everyday clinical practice. However, the risks of resistant hypertension, as well as the benefits of treatment and control of blood pressure in patients with resistant hypertension remain vaguely clarified. Data from small clinical studies and observational cohorts suggest that patients with resistant hypertension are at increased cardiovascular risk, while control of blood pressure offers substantial benefits. It has to be noted however that data from appropriate large randomized studies are missing, and resistant hypertension remains remarkably understudied. Resistant hypertension has attracted significant scientific interest lately, as new therapeutic modalities become available. The interventional management of resistant hypertension either by carotid baroreceptor stimulation or renal sympathetic denervation is currently under investigation with promising preliminary results. This review presents available evidence regarding the benefits of treatment and control of blood pressure in patients with resistant hypertension and offers a critical evaluation of existing data in this field. SAGE-Hindawi Access to Research 2010-12-22 /pmc/articles/PMC3014695/ /pubmed/21234402 http://dx.doi.org/10.4061/2011/318549 Text en Copyright © 2011 Michael Doumas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Doumas, Michael Papademetriou, Vasilios Douma, Stella Faselis, Charles Tsioufis, Konstantinos Gkaliagkousi, Eugene Petidis, Konstantinos Zamboulis, Chrysanthos Benefits from Treatment and Control of Patients with Resistant Hypertension |
title | Benefits from Treatment and Control of Patients with Resistant Hypertension |
title_full | Benefits from Treatment and Control of Patients with Resistant Hypertension |
title_fullStr | Benefits from Treatment and Control of Patients with Resistant Hypertension |
title_full_unstemmed | Benefits from Treatment and Control of Patients with Resistant Hypertension |
title_short | Benefits from Treatment and Control of Patients with Resistant Hypertension |
title_sort | benefits from treatment and control of patients with resistant hypertension |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014695/ https://www.ncbi.nlm.nih.gov/pubmed/21234402 http://dx.doi.org/10.4061/2011/318549 |
work_keys_str_mv | AT doumasmichael benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT papademetriouvasilios benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT doumastella benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT faselischarles benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT tsioufiskonstantinos benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT gkaliagkousieugene benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT petidiskonstantinos benefitsfromtreatmentandcontrolofpatientswithresistanthypertension AT zamboulischrysanthos benefitsfromtreatmentandcontrolofpatientswithresistanthypertension |